ORAL CONTRIBUTED SESSION 22: Clinical Trials IV
Tracks
PARALLEL HALL 2 (Maurice Saltiel III Hall)
| Wednesday, July 24, 2024 |
| 9:00 AM - 10:40 AM |
| PARALLEL HALL 2 (Maurice Saltiel III Hall) |
Presentations
Dr. Zhujie Gu
University of Cambridge, United Kingdom
OC22-1 | Joint modelling of survival and longitudinal data for sequential decision-making in clinical trials
9:00 AM - 9:18 AM
Dr. Kelly Van Lancker
PostDoc
Dept of Applied Mathematics, Computer Science & Statistics, University of Ghent, Belgium
OC22-2 | Automated, efficient and model-free inference for randomised clinical trials via data-driven covariate adjustment
9:18 AM - 9:36 AM
Dr. Harry Parr
Statistics and Data Science Innovation Hub (SDS-IH), GSK, London, United Kingdom
OC22-3 | An overview of prognostic scoring adjustments: Applied to neurodegenerative diseases
9:36 AM - 9:54 AM
Ms. Mollie Payne
King's College London, United Kingdom
OC22-4 | Principal treatment effects: A novel approach to non-linear dose-response modelling in complex interventions
9:54 AM - 10:12 AM
Ms. Teresa Lee
University College London, United Kingdom
OC22-5 | Estimating the Complier Average Causal Effect (CACE) for randomised therapy trials – Is a binary compliance definition appropriate?
10:12 AM - 10:30 AMChair
Stefan Michiels
Gustave Roussy/Inserm, Villejuif, France
